Days after Delhi Lt Governor VK Saxena referred a matter pertaining to drugs failing quality standard tests to CBI, Raj Niwas officials on Wednesday reported another medicine used for treating seizures and epilepsy turning out to be spurious.
Mr Saxena had last week recommended a CBI inquiry into the alleged supply of drugs that "failed quality standard tests" and have the "potential of endangering lives."
According to officials, another drug sample taken from Delhi government hospitals was failed by the RDTL, or Regional Drug Testing Laboratory, in Chandigarh.
This time an anti-epilepsy drug called 'Sodium Valproate' was found to be falling short of the standards.
The report was issued by a government analyst on December 22, an official said.
The drugs that have been found to be of "sub-standard quality" included Cephalexin, a critical life-saving antibiotic used for the treatment of lung and urinary tract infections, according to officials.
They also included Dexamethasone, a steroid used for curing life-threatening inflammation in lungs, joints, and swelling in the body, anti-epilepsy and anti-anxiety psychiatric drug Levetiracetam, and anti-hypertension drug Amlodipine, they said.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
Gadgets 360 With Technical Guruji: Samsung Galaxy Watch Ultra
Tihar Inmate Dies Of 'Drug Overdose', Family Alleges Foul Play Mamata Banerjee's Big Claim Over Key Meet Fact-Checked By Centre Why Was Woman In Bengaluru Hostel Murdered? What Initial Probe Reveals Boyfriend Stabs 20-Year-Old To Death Near Mumbai, Dumps Body In Bushes: Cops French Rail Chief Says Trains To Run Normally From Monday After Sabotage Lines Of Communication In South China Sea Critical For Peace: S Jaishankar Kamala Harris Cuts Down Donald Trump's Lead Sharply, Show Latest Polls Track Latest News Live on NDTV.com and get news updates from India and around the world.